Literature DB >> 8050085

Establishment of a new lung sarcoma cell line from a human lung carcinosarcoma.

A Leibovitz1, J Wymer, K Massey, F H Thompson, M A Nelson.   

Abstract

A cell-line (UACC 2561), was established from a biopsy specimen of a lung carcinosarcoma. The patient had Stage III non-small cell lung cancer. Characterization of this cell line revealed highly aneuploid cells containing multiple clonal chromosome alterations with growth in nude mice within 3 weeks following subcutaneous injection. The cell line UACC 2561 stained positive for vimentin and displayed resistance to a variety of chemotherapeutic agents. Polymerase chain reaction followed by single-strand conformational polymorphism analysis revealed the presence of a K-ras 12 codon mutation. This mutation was confirmed by mutation specific PCR analysis for mutant K-ras alleles and direct DNA sequencing to be a GGT to GTT at codon 12 of the K-ras gene. Examination by PCR-SSCP for p53 mutations did not reveal any point mutations in exon 5-8 of the p53 gene. This relatively rare cell line may represent a useful model to investigate human lung sarcomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050085     DOI: 10.1016/0304-3835(94)90005-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Establishment and characterization of a cell line (NABCA) derived from metastatic lymph nodes of breast scirrhous carcinoma.

Authors:  Satoshi Ohi; Shigeya Kyoda; Isao Tabei; Kouzou Ninomiya; Kayoko Sugiyama; Hisashi Hashimoto; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2006-11       Impact factor: 4.174

2.  Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factor.

Authors:  Ryoji Harada; Yoshiki Uemura; Makoto Kobayashi; Adriana Zamecnikova; Hideshi Nakata; Takahiro Taguchi; Mutsuo Furihata; Yuji Otsuki; Hirokuni Taguchi
Journal:  Jpn J Cancer Res       Date:  2002-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.